PMA device
Axonics Sacral Neuromodulation System
Boston Scientific Corporation · Implanted Electrical Device Intended For Treatment Of Fecal Incontinence (QON, Class III) · First FDA decision Sep 6, 2019, newest Aug 7, 2026Fecal incontinence and constipation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
22
PMA pathway
Device trials
5
Naming "Axonics Sacral Neuromodulation"
MAUDE reports
11
Brand "Axonics Sacral Neuromodulation", since 2015
PubMed studies
0
Mentioning "Axonics Sacral Neuromodulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Axonics Sacral Neuromodulation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 22 decisions filed under this name.
- Axonics Sacral Neuromodulation SystemPMA supplement
P190006-S113 · Decided Aug 7, 2026 · 56 days after receipt · Normal 180 Day Track
Device type: Implanted electrical device intended for treatment of fecal incontinence (QON) · GI, Urology & Nephrology
5 more FDA decisions with a free account
Older decisions: P190006-S079, P190006-S078, P190006-S076, P190006-S071, P190006-S066, P190006-S063, P190006-S062, P190006-S061, P190006-S056, P190006-S054, P190006-S038, P190006-S025, P190006-S024, P190006-S015, P190006-S011, P190006
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Sacral Nerve Stimulation for the Treatment of Urinary and Fecal IncontinenceLocal determinationIn effectL39543Palmetto GBAUpdated Sep 12, 2023
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of WoundsNational determinationOn the books270.1Updated Nov 4, 2026
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Electrical Aversion Therapy for Treatment of AlcoholismNational determinationOn the books130.4Updated Jun 10, 2020
- Biofeedback Therapy for the Treatment of Urinary IncontinenceNational determinationOn the books30.1.1Updated Sep 24, 2015
- Home Health-Surface Electrical Stimulation in the Treatment of DysphagiaLocal determinationIn effectL34565Palmetto GBAUpdated Nov 21, 2023
- Surface Electrical Stimulation in the Treatment of DysphagiaLocal determinationIn effectL34578Palmetto GBAUpdated Aug 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Axonics Sacral Neuromodulation", any status and sponsor, newest update first.
Axonics, Inc.Not on our public-company list
NCT07335484 · 75 participants (planned) · Start Apr 30, 2026 · Primary completion Nov 2026
Device: Axonics External Trial System (ETS) · For: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Fecal Incontinence (FI) and 1 more
Sites: Birmingham, Alabama; Macon, Georgia; Chicago, Illinois · 6 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Axonics Sacral Neuromodulation", and for the whole product code for context.
This brand
11 reports: 3 malfunction, 5 injury, 0 death
Whole product code QON
10 reports: 3 malfunction, 7 injury, 0 death
Newest reports for this brand
MW6004166 · Received Oct 19, 2026
Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Device problem as coded: Connection Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- PNE Lead Implant Kit REF: 1701Open, Classified
Z-0198-2027 · Started Jul 15, 2024 · Posted by FDA Oct 16, 2026
Reason given: Retroactively Reported: 10mL luer lock syringes included in kit may leak , break or experience other issues that may pose a risk to users.
Cause as FDA categorized it: Component change control · Device type: Stimulator, Electrical, Implantable, For Incontinence (EZW)
Published research
The most relevant PubMed records for "Axonics Sacral Neuromodulation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QON.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- InterStim® Sacral Nerve Stimulation Therapy System / Bowel ControlMedtronic Neuromodulation · PMA 2018
- Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel ControlMedtronic Neuromodulation · PMA 2015
- Test Stimulation Lead Bulk Accessory,test Stimulation Lead KitMedtronic Neuromodulation · PMA 2013
- Model 3058 Interstim II NeurostimulatorMedtronic Neuromodulation · PMA 2012
- Interstim SystemMedtronic Neuromodulation · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.